{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,30]],"date-time":"2025-07-30T16:56:42Z","timestamp":1753894602784,"version":"3.41.2"},"reference-count":106,"publisher":"IMR Press","issue":"2","license":[{"start":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T00:00:00Z","timestamp":1639958400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Front. Biosci. (Elite Ed)"],"abstract":"<jats:p>Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) is a lethal virus that was detected back on 31st December 2019 in Wuhan, Hubei province in China, and since then this virus has been spreading across the globe causing a global outbreak and has left the world fighting against the virus. The disease caused by the SARS-CoV-2 was named COVID-19 and this was declared a pandemic disease by the World Health Organization on 11th March 2020. Several nations are trying to develop a vaccine that can save millions of lives. This review outlines the morphological features of the virus describing the outer and inner structures of the virus along with the entry mechanism of the virus into the host body and the infection process. Detailed reports of global outbreak along with preventive measures have also been included, with special emphasis on China, the United States of America, India, Italy, and South Korea. Broad-spectrum antiviral drugs being used at various health care centres around the world, namely Remdesivir, Camostat &amp; Nafamostat, Famotidine, Chloroquine &amp; Hydroxychloroquine, Lopinavir\/ritonavir, Ivermectin, and Tocilizumab &amp; Sarilumab have also been included. World Health Organization guidelines on preventive measures and use of soaps, alcohol-based hand-rubs and wearing face masks have also been described. The vaccines that are in one of the phases of human trials, namely Oxford University\u2019s vaccine, the United States-based Moderna\u2019s vaccine, India\u2019s Covaxin and the Russian vaccine, have also been incorporated in the review article.<\/jats:p>","DOI":"10.52586\/e884","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T08:36:54Z","timestamp":1639989414000},"source":"Crossref","is-referenced-by-count":3,"title":["COVID-19: morphology and mechanism of the SARS-CoV-2, global outbreak, medication, vaccines and future of the virus"],"prefix":"10.31083","volume":"13","author":[{"given":"Prithu","family":"Bhattacharyya","sequence":"first","affiliation":[{"name":"Department of Botany, Dinabandhu Andrews College, Garia, Kolkata, 700084 West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sunandana","family":"Das","sequence":"first","affiliation":[{"name":"Department of Botany, Dinabandhu Andrews College, Garia, Kolkata, 700084 West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sahasrabdi","family":"Aich","sequence":"first","affiliation":[{"name":"Department of Botany, Vivekananda College, Thakurpukur, Kolkata, 700063 West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Sarkar","sequence":"first","affiliation":[{"name":"Department of Botany, Dinabandhu Andrews College, Garia, Kolkata, 700084 West Bengal, India"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"16242","published-online":{"date-parts":[[2021,12,20]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","unstructured":"Alzahrani FA, Saadeldin IM, Ahmad A, Kumar D, Azhar EI, Siddiqui AJ, et al. The Potential Use of Mesenchymal Stem Cells and their Derived Exosomes as Immunomodulatory Agents for COVID-19 Patients. Stem Cells International. 2020; 2020: 1\u201311.","DOI":"10.1155\/2020\/8835986"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"Shereen MA, Khan S, Kazmi A, Bashir N, Siddique R. COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of Advanced Research. 2020; 24: 91\u201398.","DOI":"10.1016\/j.jare.2020.03.005"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"Kumar R, Nagpal S, Kaushik S, Mendiratta S. COVID-19 diagnostic approaches: different roads to the same destination. VirusDisease. 2020; 31: 97\u2013105.","DOI":"10.1007\/s13337-020-00599-7"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Siddiqui AJ, Jahan S, Ashraf SA, Alreshidi M, Ashraf MS, Patel M, et al. Current status and strategic possibilities on potential use of combinational drug therapy against COVID-19 caused by SARS-CoV-2. Journal of Biomolecular Structure and Dynamics. 2020: 1\u201314.","DOI":"10.1080\/07391102.2020.1802345"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Siddiqui AJ, Danciu C, Ashraf SA, Moin A, Singh R, Alreshidi M, et al. Plants-derived biomolecules as potent antiviral phytomedicines: New insights on ethnobotanical evidences against coronaviruses. Plants. 2020; 9: 1244.","DOI":"10.3390\/plants9091244"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Surti M, Patel M, Adnan M, Moin A, Ashraf SA, Siddiqui AJ, et al. Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2 key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study. RSC Advances. 2020; 10: 37707\u201337720.","DOI":"10.1039\/D0RA06379G"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"Holshue ML, DeBolt C, Lindquist S, Lofy KH, Wiesman J, Bruce H, et al. First Case of 2019 Novel Coronavirus in the United States. New England Journal of Medicine. 2020; 382: 929\u2013936.","DOI":"10.1056\/NEJMoa2001191"},{"key":"ref8","unstructured":"Meyer R. There\u2019s One Big Reason the U.S. Economy Can\u2019t Reopen. Available at: https:\/\/www.theatlantic.com\/science\/archive\/2020\/05\/theres-only-one-way-out-of-this-mess\/611431\/ (Accessed: 12 October 2020)."},{"key":"ref9","unstructured":"Wang J, Huth L, Umlauf T. How the CDC\u2019s Restrictive Testing Guidelines Hid the Coronavirus Epidemic: U.S. health officials\u2019 slow response to the global spread led to a lag in testing. The Wall Street Journal. 2020."},{"key":"ref10","unstructured":"Wamsley L. Trump Administration Announces Measures To Speed Coronavirus Testing. NPR. 2020. Available at: https:\/\/www.npr.org\/sections\/health-shots\/2020\/03\/13\/815363944\/trump-administration-announces-measures-to-speed-coronavirus-testing (Accessed: 12 October 2020)."},{"key":"ref11","unstructured":"Woods A. FDA authorizes coronavirus test that could drastically speed up screening. Fox News. 2020. Available at: https:\/\/www.foxnews.com\/health\/fda-authorizes-coronavirus-test-could-speed-screening (Accessed: 12 October 2020)."},{"key":"ref12","unstructured":"Mak T, Pfeiffer S, Jingnan H, Benincasa R, Smith G, Shapiro J, et al. A Month After Emergency Declaration, Trump\u2019s Promises Largely Unfulfilled. NPR. 2020. Available at: https:\/\/www.npr.org\/2020\/04\/13\/832797592\/a-month-after-emergency-declaration-trumps-promises-largely-unfulfilled (Accessed: 12 October 2020)."},{"key":"ref13","unstructured":"Blake A. A timeline of Trump playing down the coronavirus threat. Available at: https:\/\/www.washingtonpost.com\/politics\/2020\/03\/12\/trump-coronavirus-timeline\/ (Accessed: 12 October 2020)."},{"key":"ref14","unstructured":"Stolberg SG, Stockman F, LaFraniere S. Testing Remains Scarce as Governors Weigh Reopening States. The New York Times. 2020. Available at: https:\/\/www.nytimes.com\/2020\/04\/25\/us\/politics\/virus-testing-shortages-states-trump.html (Accessed: 12 October 2020)."},{"key":"ref15","unstructured":"Sprunt B, Montanaro D. FACT CHECK: Trump Claims U.S. Testing For Coronavirus Most Per Capita\u2014It\u2019s Not. NPR. 2020. Available at: https:\/\/www.npr.org\/sections\/coronavirus-live-updates\/2020\/04\/02\/826368789\/fact-check-trump-claims-u-s-testing-for-coronavirus-most-per-capita-its-not (Accessed: 12 October 2020)."},{"key":"ref16","unstructured":"TT of Israel. Defence minister claims Israel\u2019s biological institute developed virus antibody. The Times of Israel. 2020. Available at: https:\/\/www.timesofisrael.com\/defense-minister-claims-israels-biological-institute-developed-virus-vaccine\/ (Accessed: 12 October 2020)."},{"key":"ref17","unstructured":"Branswell H. CDC launches studies to get more precise count of undetected Covid-19 cases. STAT. 2020. Available at: https:\/\/www.statnews.com\/2020\/04\/04\/cdc-launches-studies-to-get-more-precise-count-of-undetected-covid-19-cases\/ (Accessed: 12 October 2020)."},{"key":"ref18","unstructured":"Resnick B. Social distancing can\u2019t last forever. Here\u2019s what should come next. RealClear. 2020. Available at: https:\/\/www.realclearpolicy.com\/2020\/03\/31\/social_distancing_cant_last_forever_heres_what_comes_next_487888.html (Accessed: 12 October 2020)."},{"key":"ref19","unstructured":"Burton TM, Restuccia A, Hopkins JS. U.S. Moves to Expand Array of Drug Therapies Deployed Against Coronavirus. The Wall Street Journal. 2020."},{"key":"ref20","unstructured":"Pe\u00f1aloza M. Feds Warn Merchants Against Coronavirus Treatment Claims. NPR. 2020. Available at: https:\/\/www.wwno.org\/2020-04-01\/feds-warn-merchants-against-coronavirus-treatment-claims (Accessed: 12 October 2020)."},{"key":"ref21","unstructured":"The New York Times. Michigan Militia Puts Armed Protest in the Spotlight. 2020. Available at: https:\/\/apnews.com\/article\/gun-politics-virus-outbreak-ap-top-news-az-state-wire-mi-state-wire-c04cc1df0c958053489bd24bb7fce93f (Accessed: 12 October 2020)."},{"key":"ref22","unstructured":"Gearan A, Wagner J. Trump expresses support for angry anti-shutdown protesters as more states lift coronavirus lockdowns. The Washington Post. 2020. Available at: https:\/\/www.washingtonpost.com\/politics\/trump-expresses-support-for-angry-anti-shutdown-protesters-as-more-states-lift-coronavirus-lockdowns\/2020\/05\/01\/25570dbe-8b9f-11ea-8ac1-bfb250876b7a_story.html (Accessed: 12 October 2020)."},{"key":"ref23","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. 2021. Available at: https:\/\/covid19.who.int\/ (Accessed: 12 October 2020)."},{"key":"ref24","unstructured":"Severgnini C. Coronavirus, first two cases in Italy \u201cTwo Chinese people are on vacation in Rome\u201d They arrived in Milan on 23 January. Available at: https:\/\/www.corriere.it\/cronache\/20_gennaio_30\/coronavirus-italia-corona-9d6dc436-4343-11ea-bdc8-faf1f56f19b7.shtml (Accessed: 12 October 2020)."},{"key":"ref25","unstructured":"Frignani R. Coronavirus, first two cases in Italy: two Chinese tourists, husband and wife. In Italy for 7 days (landed in Milan). Available at: https:\/\/www.corriere.it\/cronache\/20_gennaio_31\/virus-primi-due-casi-italia-due-cinesi-marito-moglie-italia-dieci-giorni-e365df1c-43b3-11ea-bdc8-faf1f56f19b7.shtml (Accessed: 12 October 2020)."},{"key":"ref26","unstructured":"Anzolin E, Amante A. First Italian dies of coronavirus as outbreak flares in north. Ynetnews. 2020. Available at: https:\/\/www.reuters.com\/article\/us-china-health-italy-idUSKBN20F0UI (Accessed: 12 October 2020)."},{"key":"ref27","unstructured":"Ravizza S. Coronavirus: first cases in Milan. What do we know about the new infections in Lombardy, Veneto and Piedmont. Available at: https:\/\/www.corriere.it\/cronache\/20_febbraio_22\/coronavirus-italia-nuovi-contagi-lombardia-veneto-245e72d4-5540-11ea-8418-2150c9ca483e.shtml (Accessed: 12 October 2020)."},{"key":"ref28","unstructured":"Avvenire. Coronavirus. Hit all regions. Civil Protection: here are the updated numbers. Available at: https:\/\/www.avvenire.it\/attualita\/pagine\/coronavirus-aggiornamento-5-marzo-2020 (Accessed: 12 October 2020)."},{"key":"ref29","unstructured":"Ananasso A, de Stabile E, Gagliardi G, Matteucci P. Coronavirus in Italy: all the news from February. Available at: https:\/\/www.repubblica.it\/cronaca\/2020\/02\/22\/news\/coronavirus_in_italia_aggiornamento_ora_per_ora-249241616\/ (Accessed: 12 October 2020)."},{"key":"ref30","unstructured":"Bartoloni M. Coronavirus, how quarantine works and what threatens those who violate it (arrest). Available at: https:\/\/www.ilsole24ore.com\/art\/coronavirus-chi-viola-quarantena-rischia-l-arresto-fino-tre-mesi-ACrcnLLB?refresh_ce=1 (Accessed: 12 October 2020)."},{"key":"ref31","unstructured":"BBC. Coronavirus: Venice Carnival closes as Italy imposes lockdown. 2020. Available at: https:\/\/www.bbc.com\/news\/world-europe-51602007 (Accessed: 12 October 2020)."},{"key":"ref32","unstructured":"BBC. Coronavirus: Northern Italy quarantines 16 million people. 2020. Available at: https:\/\/www.bbc.com\/news\/world-middle-east-51787238 (Accessed: 12 October 2020)."},{"key":"ref33","unstructured":"BBC. Coronavirus: Italy extends emergency measures nationwide. 2020. Available at: https:\/\/www.bbc.com\/news\/world-europe-51810673 (Accessed: 12 October 2020)."},{"key":"ref34","unstructured":"Safi M, Giuffrida A, Farrer M. Coronavirus: Italy bans any movement inside country as toll nears 5,500. 2020. Available at: https:\/\/www.theguardian.com\/world\/2020\/mar\/22\/italian-pm-warns-of-worst-crisis-since-ww2-as-coronavirus-deaths-leap-by-almost-800 (Accessed: 12 October 2020)."},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Lau H, Khosrawipour V, Kocbach P, Mikolajczyk A, Ichii H, Schubert J, et al. Internationally lost COVID-19 cases. Journal of Microbiology, Immunology and Infection. 2020; 53: 454\u2013458.","DOI":"10.1016\/j.jmii.2020.03.013"},{"key":"ref36","unstructured":"Reuters. The total number of Italian coronavirus cases could be \u201810 times higher\u2019 than known tally, according to one official. Available at: https:\/\/www.cnbc.com\/2020\/03\/24\/italian-coronavirus-cases-seen-10-times-higher-than-official-tally.html (Accessed: 12 October 2020)."},{"key":"ref37","unstructured":"The Local. Italy\u2019s coronavirus deaths rise slightly, but new cases continue to slow. 2020. Available at: https:\/\/www.thelocal.it\/20200330\/latest-coronavirus-deaths-italy (Accessed: 12 October 2020)."},{"key":"ref38","unstructured":"Agenzia Italia. \u201cItaly has peaked,\u201d says the Higher Institute of Health. 2020. Available at: https:\/\/www.agi.it\/cronaca\/news\/2020-03-31\/coronavirus-istituto-superiore-sanit-picco-8038210\/ (Accessed: 12 October 2020)."},{"key":"ref39","unstructured":"The Local. Pressure on Italy\u2019s intensive care wards eases as new coronavirus cases slow again. 2020. Available at: https:\/\/www.thelocal.it\/20200406\/latest-coronavirus-numbers-italy (Accessed: 12 October 2020)."},{"key":"ref40","unstructured":"della Sera C. Schools closed for Coronavirus in Lombardy, Veneto and Emilia Romagna: the list of municipalities. Available at: https:\/\/www.corriere.it\/cronache\/20_febbraio_21\/scuole-chiuse-il-coronavirus-lombardia-lodi-piacenza-codogno-a190ccee-54bd-11ea-9196-da7d305401b7.shtml (Accessed: 12 October 2020)."},{"key":"ref41","unstructured":"Matteucci P. Coronaviruses, school and university closures, demonstrations and public places: measures region by region. 2020. Available at: https:\/\/www.repubblica.it\/cronaca\/2020\/02\/23\/news\/coronavirus_scuole_chiuse_e_niente_carnevale_tutti_i_provvedimenti-249355737\/ (Accessed: 12 October 2020)."},{"key":"ref42","unstructured":"Lorello M. Coronavirus, for a suspended teaching week in Lombardy universities. Milan municipality and large companies: at-risk workers stay at home. 2020. Available at: https:\/\/milano.repubblica.it\/cronaca\/2020\/02\/22\/news\/coronavirus_il_comune_di_milano_sospende_dal_lavoro_i_dipendenti_che_abitano_delle_zone_coinvolte-249252812\/ (Accessed: 12 October 2020)."},{"key":"ref43","unstructured":"della Sera C. Coronavirus, trains stopped for hours in Lecce and Milan. Convoys do not stop in the municipalities at risk of the Lodigiano. Available at: https:\/\/www.corriere.it\/cronache\/20_febbraio_22\/coronavirus-treni-fermi-ore-lecce-milano-nessuno-stop-comuni-rischio-lodigiano-431e997c-553d-11ea-8418-2150c9ca483e.shtml (Accessed: 12 October 2020)."},{"key":"ref44","unstructured":"Repubblica L. The closed staircase for the coronavirus: in more than two centuries it had happened only six times. 2020. Available at: https:\/\/milano.repubblica.it\/cronaca\/2020\/02\/23\/news\/coronavirus_scala_milano_chiusure_nella_storia-249380233\/ (Accessed: 12 October 2020)."},{"key":"ref45","unstructured":"Giannattasio M. Coronavirus, closed schools, gyms and clubs: guide to curfew in the North. Available at: https:\/\/milano.corriere.it\/notizie\/cronaca\/20_febbraio_23\/coronavirus-chiuse-scuole-palestre-locali-guida-coprifuoco-nord-00193c74-568a-11ea-b447-d9646dbdb12a.shtml (Accessed: 12 October 2020)."},{"key":"ref46","unstructured":"Avvenire. Coronavirus. Churches open but Masses suspended. Archbishop Delpini\u2019s Prayer. 2020. Available at: https:\/\/www.avvenire.it\/chiesa\/pagine\/milano-l-arcivescovo-delpini-un-pensiero-di-benedizione (Accessed: day month year)."},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020; 395: 497\u2013506.","DOI":"10.1016\/S0140-6736(20)30183-5"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Leitner T, Kumar S. Where did SARS-CoV-2 Come from? Molecular Biology and Evolution. 2020; 37: 2463\u20132464.","DOI":"10.1093\/molbev\/msaa162"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"Mahase E. China coronavirus: mild but infectious cases may make it hard to control outbreak, report warns. British Medical Journal. 2020; 368: m325.","DOI":"10.1136\/bmj.m325"},{"key":"ref50","unstructured":"Vara V. Coronavirus in India: how the COVID-19 could impact the fast-growing economy. 2020. Available at: https:\/\/www.pharmaceutical-technology.com\/features\/coronavirus-affected-countries-india-measures-impact-pharma-economy\/ (Accessed: 12 October 2020)."},{"key":"ref51","unstructured":"Kachroo V. Novel Coronavirus (COVID-19) in India: Current Scenario. International Journal of Research and Review. 2020; 7: 435\u2013447."},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"Negandhi H, Zodpey S, Dua A, Vasudevan A, Raja M. Our fight against the rapidly evolving COVID-19 pandemic: a review of India\u2019s actions and proposed way forward. Indian Journal of Community Medicine. 2020; 45: 117\u2013124.","DOI":"10.4103\/ijcm.IJCM_221_20"},{"key":"ref53","unstructured":"Delhi P. India\u2019s response to COVID outbreak. 2020. Available at: https:\/\/pib.gov.in\/PressReleasePage.aspx?PRID=1608727 (Accessed: 12 October 2020)."},{"key":"ref54","unstructured":"Sharma A. Truenat Beta Test for COVID-19 detection in India. Invest India. 2020. Available at: https:\/\/www.investindia.gov.in\/team-india-blogs\/truenat-beta-test-covid-19-detection-india (Accessed: 12 October 2020)."},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Kim PS. South Korea\u2019s fast response to coronavirus disease: implications on public policy and public management theory. Public Management Review. 2020; 1\u201312. (in press)","DOI":"10.1080\/14719037.2020.1766266"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"Kang J, Jang YY, Kim J, Han S, Lee KR, Kim M, et al. South Korea\u2019s responses to stop the COVID-19 pandemic. American Journal of Infection Control. 2020; 48: 1080\u20131086.","DOI":"10.1016\/j.ajic.2020.06.003"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"Lee SY, Choi SH, Park JE, Hwang S, Kwon KT. Crucial role of temporary airborne infection isolation rooms in an intensive care unit: containing the COVID-19 outbreak in South Korea. Critical Care. 2020; 24: 238.","DOI":"10.1186\/s13054-020-02944-0"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Lim S, Yoon HI, Song K, Kim ES, Kim HB. Face masks and containment of COVID-19: experience from South Korea. Journal of Hospital Infection. 2020; 106: 206\u2013207.","DOI":"10.1016\/j.jhin.2020.06.017"},{"key":"ref59","unstructured":"Chung DJ. What South Korea Teaches The World About Fighting COVID. 2020. Available at: https:\/\/www.forbes.com\/sites\/hbsworkingknowledge\/2020\/06\/16\/what-south-korea-teaches-the-world-about-fighting-covid\/?sh=6fae3a5c3e36 (Accessed: 12 October 2020)."},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"Panoutsopoulos AA. Conjunctivitis as a Sentinel of SARS-CoV-2 Infection: a need of Revision for Mild Symptoms. SN Comprehensive Clinical Medicine. 2020; 2: 859\u2013864.","DOI":"10.1007\/s42399-020-00360-7"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"Brandini DA, Takamiya AS, Thakkar P, Schaller S, Rahat R, Naqvi AR. Covid-19 and oral diseases: Crosstalk, synergy or association? Reviews in Medical Virology. 2021. (in press)","DOI":"10.1002\/rmv.2226"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Das P, Choudhuri T. Decoding the global outbreak of COVID-19: the nature is behind the scene. VirusDisease. 2020; 31: 106\u2013112.","DOI":"10.1007\/s13337-020-00605-y"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"Walls AC, Park Y, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein. Cell. 2020; 181: 281\u2013292.e6.","DOI":"10.1016\/j.cell.2020.02.058"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"Bertram S, Glowacka I, M\u00fcller MA, Lavender H, Gnirss K, Nehlmeier I, et al. Cleavage and activation of the severe acute respiratory syndrome coronavirus spike protein by human airway trypsin-like protease. Journal of Virology. 2011; 85: 13363\u201313372.","DOI":"10.1128\/JVI.05300-11"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Glowacka I, Bertram S, M\u00fcller MA, Allen P, Soilleux E, Pfefferle S, et al. Evidence that TMPRSS2 activates the severe acute respiratory syndrome coronavirus spike protein for membrane fusion and reduces viral control by the humoral immune response. Journal of Virology. 2011; 85: 4122\u20134134.","DOI":"10.1128\/JVI.02232-10"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, et al. Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1. New England Journal of Medicine. 2020; 382: 1564\u20131567.","DOI":"10.1056\/NEJMc2004973"},{"key":"ref67","unstructured":"World Health Organization. Coronavirus. Available at: https:\/\/www.who.int\/health-topics\/coronavirus#tab=tab_1 (Accessed: 12 October 2020)."},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) the Indian Journal of Pediatrics. 2020; 87: 281\u2013286.","DOI":"10.1007\/s12098-020-03263-6"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"Beiu C, Mihai M, Popa L, Cima L, Popescu MN. Frequent Hand Washing for COVID-19 Prevention can Cause Hand Dermatitis: Management Tips. Cureus. 2020; 12: e7506.","DOI":"10.7759\/cureus.7506"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"Wilder-Smith A, Chiew CJ, Lee VJ. Can we contain the COVID-19 outbreak with the same measures as for SARS? Lancet Infectious Diseases. 2020; 20: e102\u2013e107.","DOI":"10.1016\/S1473-3099(20)30129-8"},{"key":"ref71","unstructured":"World Health Organization. Coronavirus disease (COVID-19) advice for the public. Available at: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public (Accessed: 12 October 2020)."},{"key":"ref72","unstructured":"Resnick B. How soap absolutely annihilates the coronavirus. Available at: https:\/\/www.vox.com\/science-and-health\/2020\/3\/11\/21173187\/coronavirus-covid-19-hand-washing-sanitizer-compared-soap-is-dope (Accessed: 12 October 2020)."},{"key":"ref73","doi-asserted-by":"crossref","unstructured":"Tobaiqy M, Qashqary M, Al-Dahery S, Mujallad A, Hershan AA, Kamal MA, et al. Therapeutic management of patients with COVID-19: a systematic review. Infection Prevention in Practice. 2020; 2: 100061.","DOI":"10.1016\/j.infpip.2020.100061"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Shaffer L. 15 drugs being tested to treat COVID-19 and how they would work. Nature Medicine. 2020. (in press)","DOI":"10.1038\/d41591-020-00019-9"},{"key":"ref75","doi-asserted-by":"crossref","unstructured":"Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19). Journal of the American Medical Association. 2020; 323: 1824\u20131836.","DOI":"10.1001\/jama.2020.6019"},{"key":"ref76","doi-asserted-by":"crossref","unstructured":"Geleris J, Sun Y, Platt J, Zucker J, Baldwin M, Hripcsak G, et al. Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19. New England Journal of Medicine. 2020; 382: 2411\u20132418.","DOI":"10.1056\/NEJMoa2012410"},{"key":"ref77","unstructured":"World Health Organization. Q&A\u202f: Hydroxychloroquine and COVID-19. Available at: https:\/\/www.who.int\/news-room\/q-a-detail\/coronavirus-disease-covid-19-hydroxychloroquine (Accessed: 12 October 2020)."},{"key":"ref78","doi-asserted-by":"crossref","unstructured":"WHO Solidarity Trial Consortium, Pan H, Peto R, Henao-Restrepo AM, Preziosi MP, Sathiyamoorthy V, et al. Repurposed Antiviral Drugs for Covid-19 \u2014 Interim WHO Solidarity Trial Results. New England Journal of Medicine. 2021; 384: 497\u2013511.","DOI":"10.1056\/NEJMoa2023184"},{"key":"ref79","doi-asserted-by":"crossref","unstructured":"Hoffmann M, Schroeder S, Kleine-Weber H, M\u00fcller MA, Drosten C, P\u00f6hlmann S. Nafamostat Mesylate Blocks Activation of SARS-CoV-2: New Treatment Option for COVID-19. Antimicrobial Agents and Chemotherapy. 2020; 64: 1\u20133.","DOI":"10.1128\/AAC.00754-20"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Freedberg DE, Conigliaro J, Wang TC, Tracey KJ, Callahan MV, Abrams JA, et al. Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: a Propensity Score Matched Retrospective Cohort Study. Gastroenterology. 2020; 159: 1129\u20131131.e3.","DOI":"10.1053\/j.gastro.2020.05.053"},{"key":"ref81","doi-asserted-by":"crossref","unstructured":"Rajter JC, Sherman MS, Fatteh N, Vogel F, Sacks J, Rajter J. Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with Coronavirus Disease 2019. Chest. 2021; 159: 85\u201392.","DOI":"10.1016\/j.chest.2020.10.009"},{"key":"ref82","doi-asserted-by":"crossref","unstructured":"Vallejos J, Zoni R, Bangher M, Villamandos S, Bobadilla A, Plano F, et al. Ivermectin to prevent hospitalizations in patients with COVID-19 (IVERCOR-COVID19): a structured summary of a study protocol for a randomized controlled trial. Trials. 2020; 21: 965.","DOI":"10.1186\/s13063-020-04813-1"},{"key":"ref83","doi-asserted-by":"crossref","unstructured":"Heidary F, Gharebaghi R. Ivermectin: a systematic review from antiviral effects to COVID-19 complementary regimen. Journal of Antibiotics. 2020; 73: 593\u2013602.","DOI":"10.1038\/s41429-020-0336-z"},{"key":"ref84","doi-asserted-by":"crossref","unstructured":"Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020; 395: 1054\u20131062.","DOI":"10.1016\/S0140-6736(20)30566-3"},{"key":"ref85","doi-asserted-by":"crossref","unstructured":"Guaraldi G, Meschiari M, Cozzi-Lepri A, Milic J, Tonelli R, Menozzi M, et al. Tocilizumab in patients with severe COVID-19: a retrospective cohort study. Lancet Rheumatology. 2020; 2: e474\u2013e484.","DOI":"10.1016\/S2665-9913(20)30173-9"},{"key":"ref86","doi-asserted-by":"crossref","unstructured":"Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, et al. Compassionate Use of Remdesivir for Patients with Severe Covid-19. New England Journal of Medicine. 2020; 382: 2327\u20132336.","DOI":"10.1056\/NEJMc2015312"},{"key":"ref87","doi-asserted-by":"crossref","unstructured":"Spinner CD, Gottlieb RL, Criner GJ, Arribas L\u00f3pez JR, Cattelan AM, Soriano Viladomiu A, et al. Effect of Remdesivir vs Standard Care on Clinical Status at 11 Days in Patients with Moderate COVID-19: A Randomized Clinical Trial. Journal of the American Medical Association. 2020; 324: 1048\u20131057.","DOI":"10.1001\/jama.2020.16349"},{"key":"ref88","unstructured":"TI Express. Covid-19 vaccine tracker, July 28: India is at the centre of vaccine, and Moderna\u2019s phase III trials. Available at: https:\/\/indianexpress.com\/article\/explained\/covid-coronavirus-vaccine-update-6526457\/ (Accessed: 12 October 2020)."},{"key":"ref89","unstructured":"O\u2019Donnell C. Moderna, Pfizer start decisive Covid-19 vaccine trials, eye year-end launches. Reuters. 2020. Available at: https:\/\/timesofindia.indiatimes.com\/home\/science\/moderna-pfizer-start-decisive-covid-19-vaccine-trials-eye-year-end-launches\/articleshow\/77210988.cms (Accessed: 12 October 2020)."},{"key":"ref90","unstructured":"CDC. Moderna COVID-19 Vaccine Overview and Safety. 2021. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/Moderna.html (Accessed: 12 October 2020)."},{"key":"ref91","unstructured":"CDC. Pfizer-BioNTech COVID-19 Vaccine Overview and Safety. 2021. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/Pfizer-BioNTech.html (Accessed: 12 October 2020)."},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Folegatti PM, Ewer KJ, Aley PK, Angus B, Becker S, Belij-Rammerstorfer S, et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1\/2, single-blind, randomised controlled trial. Lancet. 2020; 396: 467\u2013478.","DOI":"10.1016\/S0140-6736(20)31604-4"},{"key":"ref93","unstructured":"Minseo Jeong. Oxford-AstraZeneca vaccine: What to know about side effects. 2021. Available at: https:\/\/www.medicalnewstoday.com\/articles\/oxford-astrazeneca-vaccine-what-to-know-about-side-effects (Accessed: 12 October 2020)."},{"key":"ref94","unstructured":"C Bonquin. Five most common side effects of AstraZeneca, Sinovac vaccines. 2021. Available at: https:\/\/www.cnnphilippines.com\/news\/2021\/4\/20\/Five-most-common-side-effects-AstraZeneca-Sinovac-vaccines.html (Accessed: 12 October 2020)."},{"key":"ref95","doi-asserted-by":"crossref","unstructured":"Menni C, Klaser K, May A, Polidori L, Capdevila J, Louca P, et al. Vaccine side-effects and SARS-CoV-2 infection after vaccination in users of the COVID Symptom Study app in the UK: a prospective observational study. The Lancet Infectious Diseases. 2021; 21: 939\u2013949.","DOI":"10.1016\/S1473-3099(21)00224-3"},{"key":"ref96","unstructured":"IANS. Russia 1st nation to finish human trials for Covid-19 vaccine. 2020. Available at: https:\/\/health.economictimes.indiatimes.com\/news\/industry\/russia-1st-nation-to-finish-human-trials-for-covid-19-vaccine\/76938659 (Accessed: 12 October 2020)."},{"key":"ref97","unstructured":"Beall M, Bolt B, Felton C, Germann L, Goode AL, Kyral S, et al. EpiVacCorona Vaccine. 2021. Available at: https:\/\/www.precisionvaccinations.com\/vaccines\/epivaccorona-vaccine (Accessed: 12 October 2020)."},{"key":"ref98","doi-asserted-by":"crossref","unstructured":"Jones I, Roy P. Sputnik V COVID-19 vaccine candidate appears safe and effective. Lancet. 2021; 397: 642\u2013643.","DOI":"10.1016\/S0140-6736(21)00191-4"},{"key":"ref99","unstructured":"CTA. India\u2019s first Covid-19 vaccine by Bharat Biotech to enter trials. 2020. Available at: https:\/\/www.clinicaltrialsarena.com\/news\/india-bharat-biotech-vaccine-trials\/ (Accessed: 12 October 2020)."},{"key":"ref100","unstructured":"BHARATB iotech. COVAXIN SARS-CoV-2 VACCINE BY BHARAT BIOTECH. Available at: https:\/\/www.bharatbiotech.com\/images\/covaxin\/covaxin-fact-sheet.pdf (Accessed: 12 October 2020)."},{"key":"ref101","unstructured":"Craven J. COVID-19 vaccine tracker. Regulatory Focus. 2021. Available at: https:\/\/www.raps.org\/news-and-articles\/news-articles\/2020\/3\/covid-19-vaccine-tracker (Accessed: 12 October 2020)."},{"key":"ref102","unstructured":"Terry M. UPDATED Comparing COVID-19 Vaccines: Timelines, Types and Prices. 2021. Available at: https:\/\/www.biospace.com\/article\/comparing-covid-19-vaccines-pfizer-biontech-moderna-astrazeneca-oxford-j-and-j-russia-s-sputnik-v\/ (Accessed: 12 October 2020)."},{"key":"ref103","unstructured":"Hilotin J. UAE: Ministry of Health announces 86 per cent vaccine efficacy. 2020. Available at: https:\/\/gulfnews.com\/uae\/health\/uae-ministry-of-health-announces-86-per-cent-vaccine-efficacy-1.1607490555571 (Accessed: 12 October 2020)."},{"key":"ref104","unstructured":"CDC. Johnson & Johnson\u2019s Janssen COVID-19 Vaccine Overview and Safety. 2021. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/different-vaccines\/janssen.html (Accessed: 12 October 2020)."},{"key":"ref105","unstructured":"Corum J, Zimmer C. How the Sinovac Vaccine Works. 2021. Available at: https:\/\/www.nytimes.com\/interactive\/2020\/health\/sinovac-covid-19-vaccine.html (Accessed: 12 October 2020)."},{"key":"ref106","unstructured":"Everington K. Full list of adverse reactions from China\u2019s Sinopharm vaccine revealed. 2021. Available at: https:\/\/www.taiwannews.com.tw\/en\/news\/4098913 (Accessed: 12 October 2020)."}],"container-title":["Frontiers in Bioscience-Elite"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.imrpress.com\/journal\/FBE\/13\/2\/10.52586\/E884","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T10:46:26Z","timestamp":1732704386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.imrpress.com\/journal\/FBE\/13\/2\/10.52586\/E884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,20]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021]]}},"alternative-id":["s1945-0494(21)00884-5"],"URL":"https:\/\/doi.org\/10.52586\/e884","relation":{},"ISSN":["1945-0494","1945-0508"],"issn-type":[{"type":"print","value":"1945-0494"},{"type":"electronic","value":"1945-0508"}],"subject":[],"published":{"date-parts":[[2021,12,20]]},"article-number":"272"}}